HK1025521A1 - Use of 15-keto-prostaglandin-e compounds as endothelin antagonists - Google Patents

Use of 15-keto-prostaglandin-e compounds as endothelin antagonists

Info

Publication number
HK1025521A1
HK1025521A1 HK00104940.3A HK00104940A HK1025521A1 HK 1025521 A1 HK1025521 A1 HK 1025521A1 HK 00104940 A HK00104940 A HK 00104940A HK 1025521 A1 HK1025521 A1 HK 1025521A1
Authority
HK
Hong Kong
Prior art keywords
keto
prostaglandin
compounds
endothelin antagonists
endothelin
Prior art date
Application number
HK00104940.3A
Other languages
English (en)
Inventor
Ryuji Ueno
Original Assignee
Sucampo Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sucampo Ag filed Critical Sucampo Ag
Publication of HK1025521A1 publication Critical patent/HK1025521A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK00104940.3A 1997-11-28 2000-08-08 Use of 15-keto-prostaglandin-e compounds as endothelin antagonists HK1025521A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP32783297 1997-11-28
PCT/JP1998/005143 WO1999027934A1 (fr) 1997-11-28 1998-11-16 Antagoniste d'endotheline

Publications (1)

Publication Number Publication Date
HK1025521A1 true HK1025521A1 (en) 2000-11-17

Family

ID=18203488

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00104940.3A HK1025521A1 (en) 1997-11-28 2000-08-08 Use of 15-keto-prostaglandin-e compounds as endothelin antagonists

Country Status (17)

Country Link
US (1) US6197821B1 (xx)
EP (1) EP0978284B1 (xx)
JP (1) JP4319256B2 (xx)
KR (1) KR100648868B1 (xx)
CN (1) CN1206997C (xx)
AT (1) ATE401894T1 (xx)
AU (1) AU739343B2 (xx)
CA (1) CA2279267C (xx)
DE (1) DE69839767D1 (xx)
DK (1) DK0978284T3 (xx)
ES (1) ES2310013T3 (xx)
HK (1) HK1025521A1 (xx)
NO (1) NO328460B1 (xx)
NZ (1) NZ336960A (xx)
PT (1) PT978284E (xx)
TW (1) TW592701B (xx)
WO (1) WO1999027934A1 (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002330747B2 (en) * 2001-08-31 2007-07-19 Sucampo Ag Prostaglandin analogs as chloride channel opener
AR037524A1 (es) 2001-11-14 2004-11-17 Sucampo Ag Unidad de dosificacion que comprende un analogo de prostaglandina para el tratamiento de la constipacion
US7732487B2 (en) 2001-11-19 2010-06-08 Sucampo Ag Method for treating a disease or condition responsive to opening of C1C-2 channel
TWI336254B (en) * 2002-12-27 2011-01-21 Sucampo Ag Pharmaceutical composition for treating abdominal discomfort
US20040225014A1 (en) * 2003-02-14 2004-11-11 Sucampo Ag Method for treating ocular hypertension and glaucoma
TWI384988B (zh) * 2005-01-27 2013-02-11 Sucampo Ag 處理中樞神經系統失常用之組成物
JP5213448B2 (ja) * 2005-03-04 2013-06-19 スキャンポ・アーゲー 末梢血管疾患の処置のための方法および組成物
CN103755737A (zh) * 2006-02-07 2014-04-30 株式会社·R-技术上野 用于制备前列腺素衍生物的方法
MX2008011148A (es) * 2006-02-28 2008-09-08 Sucampo Ag Metodo y composicion para tratar enfermedad pulmonar obstructiva cronica.
SG174050A1 (en) * 2006-04-13 2011-09-29 Actelion Pharmaceuticals Ltd Endothelin receptor antagonists for early stage idiopathic pulmonary fibrosis
EP2114411A2 (en) * 2007-02-27 2009-11-11 Sucampo AG Composition and method for protecting mitochondria
US20090082442A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched lubiprostone
CN102050808B (zh) * 2009-11-02 2014-03-12 上海天伟生物制药有限公司 一种前列腺素中间体的制备方法
US20120309990A1 (en) * 2009-12-18 2012-12-06 Apotex Pharmachem Inc. Processes for the Purification of Lubiprostone
CN104557845B (zh) * 2015-01-13 2020-12-22 齐鲁制药有限公司 一种鲁比前列酮化合物的制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3853951A (en) 1971-07-14 1974-12-10 American Cyanamid Co Preparation of 9-oxo-13-trans-prostenoic acid esters by alanate addition to cyclopentenone
US4018811A (en) 1972-02-11 1977-04-19 American Cyanamid Company 3-Alkyl-2-(6-carboxyhexyl)cyclopentanones and esters and salts thereof
US3981868A (en) 1973-05-31 1976-09-21 American Cyanamid Company Derivatives of 9-oxo-13-trans-prostenoic acid amides
CA1323364C (en) * 1987-01-28 1993-10-19 Ryuzo Ueno Prostaglandins e and anti ulcer agents containing same
US5362751A (en) 1988-05-11 1994-11-08 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Tracheobronchodilator using 16-substituted PGEs
JP2597649B2 (ja) * 1988-05-11 1997-04-09 株式会社上野製薬応用研究所 気管・気管支拡張剤
EP0343904B1 (en) 1988-05-23 1993-04-28 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Hypersphyxia causing composition
JPH0232031A (ja) * 1988-07-22 1990-02-01 Nippon Steel Chem Co Ltd イソプロピル化ｐ‐ターフェニル類の製造法
CA2027814C (en) * 1989-10-20 1996-07-30 Ryuji Ueno Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
CA2030344C (en) * 1989-11-22 2000-04-18 Ryuji Ueno Treatment of pulmonary dysfunction with 15-keto-prostaglandin compounds
CA2030346C (en) * 1989-11-22 2000-04-11 Ryuji Ueno Treatment of cardiac dysfunction with 15-keto-prostaglandin compounds
CA2030345C (en) * 1989-11-22 1998-12-08 Ryuji Ueno Use of 15-keto-prostaglandin compound for improvement of encephalic function
CA2039420C (en) 1990-04-04 1996-12-10 Ryuji Ueno Treatment of cataract with 15-keto-prostaglandin compounds
ATE174221T1 (de) * 1990-05-01 1998-12-15 R Tech Ueno Ltd Behandlung von pankreaskrankheit mit 15-keto- prostaglandin e-derivaten
CA2046069C (en) * 1990-07-10 2002-04-09 Ryuji Ueno Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
EP0503887B1 (en) * 1991-03-14 1996-08-28 R-Tech Ueno Ltd. Promotion of wound-healing with 15-keto-prostaglandin compounds
WO1997047595A1 (fr) 1996-06-10 1997-12-18 R-Tech Ueno, Ltd. Antagoniste de l'endotheline
JPH107574A (ja) 1996-06-17 1998-01-13 R Tec Ueno:Kk エンドセリン拮抗剤

Also Published As

Publication number Publication date
PT978284E (pt) 2008-10-07
DK0978284T3 (da) 2008-10-27
WO1999027934A1 (fr) 1999-06-10
CN1206997C (zh) 2005-06-22
EP0978284A4 (en) 2001-07-18
NO993647D0 (no) 1999-07-27
CA2279267A1 (en) 1999-06-10
NZ336960A (en) 2001-02-23
US6197821B1 (en) 2001-03-06
ES2310013T3 (es) 2008-12-16
DE69839767D1 (de) 2008-09-04
EP0978284A1 (en) 2000-02-09
CN1251040A (zh) 2000-04-19
KR20000070508A (ko) 2000-11-25
AU1053799A (en) 1999-06-16
ATE401894T1 (de) 2008-08-15
TW592701B (en) 2004-06-21
NO993647L (no) 1999-09-27
NO328460B1 (no) 2010-02-22
EP0978284B1 (en) 2008-07-23
JP4319256B2 (ja) 2009-08-26
KR100648868B1 (ko) 2006-11-24
CA2279267C (en) 2010-01-12
AU739343B2 (en) 2001-10-11

Similar Documents

Publication Publication Date Title
HK1025521A1 (en) Use of 15-keto-prostaglandin-e compounds as endothelin antagonists
AU2003211560A1 (en) Novel phenylalanine derivative
BR9813228A (pt) Formulação de 2-metil-tieno-benzodiazepina
EP1288205A4 (en) NEW PHENYLALANINE DERIVATIVES
FR09C0028I2 (fr) ANTAGONISTES DE GnRH MODIFIES AUX POSITIONS 5 ET 6
DE69714698T2 (de) Endothelin-antagonisten
WO2002047679A3 (en) Nonpeptide agonists and antagonists of vasopressin receptors
EP0997472A3 (en) Spirocyclic C-glycosides
FR2799148B3 (fr) Agrafeuse avec indication de la quantite d'agrafes restantes
TR199501132A2 (tr) Nörokinin karsitlari (antagonistleri).
BR9804027A (pt) Novos beta-ceto ésteres
BR9813817A (pt) Análogos de hemiasterlina
PT1119359E (pt) Formulacao de 2-metil-tieno-benzodiazepina
IT1302243B1 (it) Sintesi dell'1,1,1,3,3-pentafluoropropano.
ITTO990697A0 (it) Apparecchiatura di selezione d'assetto di un corpo per cerniere lampo.
IT1310462B1 (it) Procedimento ed apparecchiatura per la mappatura automatica nondistruttiva dell'elasticita' delle pelli ad uso manifatturiero.
DE9413297U1 (de) Bohrerschaftverlängerung
FR2802814B1 (fr) Association de deoxyfructosazine et d'un antidiabetique de la famille des sulfonylurees
IT241021Y1 (it) Corpo illuminante per la riflessione di vari fasci luminosi
AU2001251462A1 (en) Compositions and methods for detection of von willebrand's disease
LV12148A (lv) 2,2'-Azobisizobutironitrila iegusanas panemiens
ITMI20001799A0 (it) Accessorio multifunzionale per monitor di "personal-computer" e simili.
IT239670Y1 (it) Idro-contenitore per l'innalzamento provvisorio di argini.
GB9707132D0 (en) Biochemical markers of the human endometrium
ITMI982242A0 (it) Procedimento per la preparazione di un derivato dell'isobenzofurano

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20141116